- Home
- PTIX vs SXTP Comparison
PTIX vs SXTP Comparison
Compare PTIX & SXTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTIX
- SXTP
- Stock Information
- Founded
- PTIX 1994
- SXTP 2010
- Country
- PTIX United States
- SXTP United States
- Employees
- PTIX N/A
- SXTP N/A
- Industry
- PTIX Biotechnology: Pharmaceutical Preparations
- SXTP Biotechnology: Pharmaceutical Preparations
- Sector
- PTIX Health Care
- SXTP Health Care
- Exchange
- PTIX Nasdaq
- SXTP Nasdaq
- Market Cap
- PTIX 2.8M
- SXTP 3.4M
- IPO Year
- PTIX 2016
- SXTP 2023
- Fundamental
- Price
- PTIX $2.78
- SXTP $1.30
- Analyst Decision
- PTIX
- SXTP Buy
- Analyst Count
- PTIX 0
- SXTP 2
- Target Price
- PTIX N/A
- SXTP $7.00
- AVG Volume (30 Days)
- PTIX 104.7K
- SXTP 137.0K
- Earning Date
- PTIX 08-22-2025
- SXTP 08-13-2025
- Dividend Yield
- PTIX N/A
- SXTP N/A
- EPS Growth
- PTIX N/A
- SXTP N/A
- EPS
- PTIX N/A
- SXTP N/A
- Revenue
- PTIX N/A
- SXTP $984,494.00
- Revenue This Year
- PTIX N/A
- SXTP $81.41
- Revenue Next Year
- PTIX N/A
- SXTP $95.63
- P/E Ratio
- PTIX N/A
- SXTP N/A
- Revenue Growth
- PTIX N/A
- SXTP 128.70
- 52 Week Low
- PTIX $2.35
- SXTP $1.24
- 52 Week High
- PTIX $15.54
- SXTP $12.70
- Technical
- Relative Strength Index (RSI)
- PTIX 41.42
- SXTP 33.69
- Support Level
- PTIX $2.60
- SXTP $1.24
- Resistance Level
- PTIX $3.24
- SXTP $1.40
- Average True Range (ATR)
- PTIX 0.27
- SXTP 0.08
- MACD
- PTIX 0.02
- SXTP 0.03
- Stochastic Oscillator
- PTIX 27.69
- SXTP 30.77
About PTIX Protagenic Therapeutics Inc.
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's main compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.